In proton minibeam radiation therapy, proton minibeams are typically produced by modulating a uniform field using a multislit collimator. Multislit collimators produce minibeams of fixed length and width, and a new collimator has to be manufactured each time a new minibeam array is required, limiting its flexibility. In this work, we propose a scanning dynamic collimator for the generation of proton minibeams arrays. The new collimator system proposed is able to produce any minibeam required on an on-line basis by modulating the pencil beam spots of modern proton therapy machines, rather than a uniform field. The new collimator is evaluated through Monte Carlo simulations and the produced proton minibeams are compared with that of a multislit collimator. Furthermore, a proof of concept experiment is conducted to demonstrate the feasibility of producing a minibeam array by repositioning (i.e. scanning) a collimator. It is concluded that besides the technical challenges, the new collimator design is producing equivalent minibeam arrays to the multislit collimator, whilst is flexible to produce any minibeam array desired.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443660 | PMC |
http://dx.doi.org/10.1038/s41598-021-97941-w | DOI Listing |
Phys Med Biol
January 2025
Department of Radiation Oncology, The University of Kansas Medical Center, Department of Radiation Oncology, University of Kansas Medical Center, USA, Kansas City, Kansas, 66160-8500, UNITED STATES.
Proton minibeam radiation therapy (pMBRT) dose profile is characterized by highly heterogeneous dose in the plane perpendicular to the beam direction and rapidly changing depth dose profiles. Typically, dose measurements are benchmarked against in-house Monte Carlo simulation tools. It is essential to have a treatment planning system (TPS) that can accurately predict pMBRT doses in tissue and be available via commercial platform for preclinical and clinical use.
View Article and Find Full Text PDFFront Oncol
December 2024
Institute of Radiation Medicine (IRM), Helmholtz Zentrum München GmbH, German Research Center for Environmental Health, Neuherberg, Germany.
Cancers (Basel)
November 2024
Radiotherapy and Radiation Dosimetry, National Physical Laboratory, Teddington TW11 0LW, UK.
Med Phys
November 2024
Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Background: The clinical translation of proton minibeam radiation therapy (pMBRT) presents significant challenges, particularly in developing an optimal treatment planning technique. A uniform target dose is crucial for maximizing anti-tumor efficacy and facilitating the clinical acceptance of pMBRT. However, achieving a high peak-to-valley dose ratio (PVDR) in organs-at-risk (OAR) is essential for sparing normal tissue.
View Article and Find Full Text PDFMed Phys
November 2024
Institut Curie, PSL Research University, Radiation Oncology Department, Proton Therapy Centre, Centre Universitaire, Orsay, France.
Background: Ultra-high dose rate (UHDR/FLASH) irradiations, along with particle minibeam therapy (PMBT) are both emerging as promising alternatives to current radiotherapy techniques thanks to their improved healthy tissue sparing and similar tumor control.
Purpose: Monte Carlo (MC) modeling of a commercial machine delivering 5-7 MeV electrons at UHDR. This model was used afterward to compare measurements against simulations for an experimental setup combining both FLASH and PMBT modalities.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!